Canadian Urological Association guideline for the management of bladder and bowel dysfunction in children

Afshar, Kourosh; Santos, Joana Dos; Blais, Anne‐Sophie; Kiddoo, Darcie; Dharamsi, Nafisa; Wang, Mannan; Noparast, Maryam

doi:10.5489/cuaj.6975

Cited by 4 publications

(5 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several validated voiding scales are useful for this purpose ( 3 , 5 ), including the Dysfunctional Voiding Symptom Score (DVSS) ( 8 ) and the Vancouver Symptom Score (VSS) ( 9 ). Scored questionnaires help diagnosis, allow measurement of severity, and monitor the effectiveness of treatment ( 3 , 5 , 10 ).…”

Section: Introductionmentioning

confidence: 99%

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

et al. 2023

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

et al. 2023

View full text Add to dashboard Cite

“…Standard urotherapy and constipation management are the mainstay of treatment for BBD, and should be given as first-line therapy [ 13 , 17 ]. Pharmacotherapy of LUTD and surgical treatment should be considered only in patients who fully complied with, but failed first-line treatment after 6 months [ 2 , 18 ]. In our study, we found that BBD children treated with standard urotherapy and constipation management had significant improvement in DVSS as early as 3 months, and further improvement at 6 months.…”

Section: Discussionmentioning

confidence: 99%

Screening and management of bladder and bowel dysfunction in general pediatric outpatient clinic: a prospective observational study

et al. 2022

View full text Add to dashboard Cite

Background Bladder and bowel dysfunction (BBD) is a common disorder in children that is often associated with psychosocial and behavioral problems. Data specific to BBD in Asian children are comparatively scarce. Accordingly, this study aimed to investigate the prevalence of BBD and the response to standard urotherapy among Thai children attending the general pediatric outpatient clinic of Siriraj Hospital – Thailand’s largest national tertiary referral center. Methods Children aged 4–12 years were recruited to complete the Dysfunctional Voiding Symptom Score (DVSS) questionnaire to screen for BBD during 2018 to 2020. Standard urotherapy, which consists of education and behavior management, was prescribed to those with a DVSS score that suggests the presence of BBD. Enrolled children and their caregivers were followed-up at 3 and 6 months. The Strengths and Difficulties Questionnaire (SDQ) was completed at baseline. DVSS scores at baseline, and at 3 months and 6 months after standard urotherapy were compared using repeated measures analysis of variance (ANOVA). Results A total of 1,042 children completed the DVSS during the study period, and 90 (8.6%) were deemed to have BBD. The mean age of BBD children was 6.9 ± 2.2 years, and the female to male ratio was 2.9:1. The most common symptoms were defecation frequency (80.0%), difficult defecation (80.0%), curtsying (74.4%), urgency (68.9%), infrequent voiding (43.3%), and daytime incontinence (32.2%). Forty-one BBD children completed the SDQ, and 32.5% had scores suggestive of hyperactivity problems. Among the 24 BBD patients who were followed-up after 3 and 6 months of standard urotherapy, there was a significant improvement in DVSS results (9.5 ± 3.1 at baseline vs. 6.9 ± 3.4 at 3 months vs. 4.4 ± 3.9 at 6 months; p < 0.01). Nine of 12 patients with urinary incontinence showed complete response at 6 months. The overall Bristol stool score significantly improved from 2.6 ± 0.7 at baseline to 3.2 ± 1.0 at 6 months (p = 0.03). Conclusions BBD is a prevalent condition among Thai children that is often associated with emotional and behavioral problems. Standard urotherapy prescribed in a general pediatric outpatient clinic setting yielded favorable outcomes in Thai children with BBD.

show abstract

“…Generally, BC therapy is based on international guidelines, including those of the society of urologic oncology (SUO) [36], the National Comprehensive Cancer Network (NCCN) [37], the Canadian Urological Association (CUA) [38], the National Cancer Institute (NCI) [39], the First International Consultation on Bladder Tumors (FICBT), Consultation on Bladder Cancer (SIU-ICUD) [40], the PDQ bladder cancer [41], the American Urological Association (AUA) [42], the European Society for Medical Oncology (ESMO) [43] and the European Association of Urology (EAU) [44]. This practice has the drawback of not necessarily, accurately or appropriately recommending the options and alternatives as mentioned in the local recommendations for local clinical practice or specific cancer states.…”

Section: Redjdal Et Al Reported That the Guideline-based Dss (Gl-dss)...mentioning

confidence: 99%

Prediction of Bladder Cancer Treatment Side Effects Using an Ontology-Based Reasoning for Enhanced Patient Health Safety

2021

View full text Add to dashboard Cite

Predicting potential cancer treatment side effects at time of prescription could decrease potential health risks and achieve better patient satisfaction. This paper presents a new approach, founded on evidence-based medical knowledge, using as much information and proof as possible to help a computer program to predict bladder cancer treatment side effects and support the oncologist’s decision. This will help in deciding treatment options for patients with bladder malignancies. Bladder cancer knowledge is complex and requires simplification before any attempt to represent it in a formal or computerized manner. In this work we rely on the capabilities of OWL ontologies to seamlessly capture and conceptualize the required knowledge about this type of cancer and the underlying patient treatment process. Our ontology allows case-based reasoning to effectively predict treatment side effects for a given set of contextual information related to a specific medical case. The ontology is enriched with proofs and evidence collected from online biomedical research databases using “web crawlers”. We have exclusively designed the crawler algorithm to search for the required knowledge based on a set of specified keywords. Results from the study presented 80.3% of real reported bladder cancer treatment side-effects prediction and were close to really occurring adverse events recorded within the collected test samples when applying the approach. Evidence-based medicine combined with semantic knowledge-based models is prominent in generating predictions related to possible health concerns. The integration of a diversity of knowledge and evidence into one single integrated knowledge-base could dramatically enhance the process of predicting treatment risks and side effects applied to bladder cancer oncotherapy.

show abstract

Canadian Urological Association guideline for the management of bladder and bowel dysfunction in children

Cited by 4 publications

References 34 publications

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

Screening and management of bladder and bowel dysfunction in general pediatric outpatient clinic: a prospective observational study

Prediction of Bladder Cancer Treatment Side Effects Using an Ontology-Based Reasoning for Enhanced Patient Health Safety

Contact Info

Product

Resources

About